- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 339/02 - Cycles à cinq chaînons
Détention brevets de la classe C07D 339/02
Brevets de cette classe: 29
Historique des publications depuis 10 ans
|
2
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Dow AgroSciences LLC | 1267 |
4 |
| Cedars-Sinai Medical Center | 1088 |
4 |
| FUJIFILM Corporation | 27102 |
2 |
| Celltrion Chemical Research Institute | 6 |
2 |
| Celltrion Pharm, Inc. | 8 |
2 |
| Merck & Co., Inc. | 607 |
1 |
| Massachusetts Institute of Technology | 9795 |
1 |
| Sumitomo Chemical Company, Limited | 8808 |
1 |
| The United States of America as represented by the Secretary of the Navy | 2734 |
1 |
| Bar-Ilan University | 405 |
1 |
| Cellixbio Private Limited | 167 |
1 |
| Encore Health, LLC | 16 |
1 |
| Multi Formulations Ltd. | 15 |
1 |
| The Penn State Research Foundation | 1423 |
1 |
| Rhodia Operations | 1645 |
1 |
| Sami Labs Limited | 114 |
1 |
| Sulfidris S.r.l. | 4 |
1 |
| The UAB Research Foundation | 629 |
1 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1338 |
1 |
| Diab R&D 1 | 2 |
1 |
| Autres propriétaires | 0 |